Financhill
Sell
27

ELV Quote, Financials, Valuation and Earnings

Last price:
$381.00
Seasonality move :
2.51%
Day range:
$378.98 - $385.38
52-week range:
$362.21 - $567.26
Dividend yield:
1.71%
P/E ratio:
13.88x
P/S ratio:
0.51x
P/B ratio:
2.02x
Volume:
1.2M
Avg. volume:
1.8M
1-year change:
-20.68%
Market cap:
$88.3B
Revenue:
$171.3B
EPS (TTM):
$27.43

Earnings Data

Next earnings date for ELV
Jan 24
2025
Most recent earnings per share
$4.36
Missed by $5.29
(Oct 17/2024)
Consensus Estimate
$9.65
(Oct 17/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ELV Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $45.1B -- -- $10.20 --
01/24/2025 Q4 $44.5B -- -- $3.87 --
10/17/2024 Q3 $43.1B $45.1B $4.36 $9.65 -$5.29
07/17/2024 Q2 $42.9B $43.6B $9.85 $10.01 -$0.16
04/18/2024 Q1 $42.4B $42.6B $9.59 $10.53 -$0.94
01/24/2024 Q4 $42.2B $42.6B $3.63 $5.59 -$1.96
10/18/2023 Q3 -- -- $5.45 $8.46 -$3.01
07/19/2023 Q2 -- -- $7.79 $8.77 -$0.98
04/19/2023 Q1 -- -- $8.30 $9.28 -$0.98
01/25/2023 Q4 -- -- $3.93 $5.19 -$1.26
10/19/2022 Q3 -- -- $6.62 $7.15 -$0.53
07/20/2022 Q2 -- -- $6.73 -- --
04/20/2022 Q1 -- -- $7.32 -- --
12/31/2021 Q4 -- -- $4.63 -- --
09/30/2021 Q3 -- -- $6.13 -- --
06/30/2021 Q2 -- -- $7.25 -- --
03/31/2021 Q1 -- -- $6.71 -- --
12/31/2020 Q4 -- -- $2.19 -- --
09/30/2020 Q3 -- -- $0.87 -- --
06/30/2020 Q2 -- -- $8.91 -- --
03/31/2020 Q1 -- -- $5.94 -- --
12/31/2019 Q4 -- -- $3.62 -- --
09/30/2019 Q3 -- -- $4.55 -- --
06/30/2019 Q2 -- -- $4.36 -- --
03/31/2019 Q1 -- -- $5.91 -- --
12/31/2018 Q4 -- -- $1.61 -- --
09/30/2018 Q3 -- -- $3.62 -- --
06/30/2018 Q2 -- -- $3.98 -- --
03/31/2018 Q1 -- -- $4.99 -- --
12/31/2017 Q4 -- -- $4.67 -- --
09/30/2017 Q3 -- -- $2.80 -- --
06/30/2017 Q2 -- -- $3.16 -- --
03/31/2017 Q1 -- -- $3.73 -- --
12/31/2016 Q4 -- -- $1.37 -- --
09/30/2016 Q3 -- -- $2.30 -- --
06/30/2016 Q2 -- -- $2.91 -- --
03/31/2016 Q1 -- -- $2.63 -- --
12/31/2015 Q4 -- -- $0.68 -- --
09/30/2015 Q3 -- -- $2.43 -- --
06/30/2015 Q2 -- -- $3.13 -- --
03/31/2015 Q1 -- -- $3.09 -- --

Elevance Health Earnings Questions

  • How Much did Elevance Health Generate in Revenue Last Quarter?

    Elevance Health reported $45.1B worth of top line sales in its most recent quarter.

  • Did Elevance Health Beat Earnings Last Quarter?

    Elevance Health announced earnings per share of $4.36 which represents a miss of analyst forecast a $9.65 per share.

  • Is Elevance Health Profitable?

    Elevance Health reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Elevance Health EPS Next Year?

    Elevance Health's earnings are forecast to grow from $25.22 per share to $32.97 per share next year representing an increase of 30.97%.

  • When is Elevance Health's Earnings Date?

    Elevance Health's next earnings date is January 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is down 0% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is down 0.1% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 9.58% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock